These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Mass screening for prostate cancer is the best approach to early diagnosis and treatment of prostate cancer]. Zhao XJ; Kong XB; Wang WH Zhonghua Nan Ke Xue; 2003 Nov; 9(8):563-5, 568. PubMed ID: 14689882 [TBL] [Abstract][Full Text] [Related]
6. Current concepts in the treatment of prostate cancer. Hirsch PJ N J Med; 2001 Feb; 98(2):11. PubMed ID: 11221436 [No Abstract] [Full Text] [Related]
7. Current immunotherapeutic strategies in prostate cancer. Grosso JF; Drake CG Surg Oncol Clin N Am; 2007 Oct; 16(4):861-71, x. PubMed ID: 18022549 [TBL] [Abstract][Full Text] [Related]
8. Treatment of radiation failure in prostate cancer. Chin JL; Izawa JI Can J Urol; 2006 Apr; 13 Suppl 2():48-51. PubMed ID: 16672129 [TBL] [Abstract][Full Text] [Related]
9. [Current opinions on the treatment of androgen-independent prostate cancer]. Guan XX; Chen LB Zhonghua Nan Ke Xue; 2006 Nov; 12(11):1021-5. PubMed ID: 17146932 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of localized prostatic cancer--different alternatives. Patients with localized prostatic cancer must actively participate in the choice of therapy]. Adolfsson J Lakartidningen; 2000 Sep; 97(36):3870-4. PubMed ID: 11036336 [TBL] [Abstract][Full Text] [Related]
11. Prostate cancer gene therapy: outcome of basic research and clinical trials. Nasu Y; Djavan B; Marberger M; Kumon H Tech Urol; 1999 Dec; 5(4):185-90. PubMed ID: 10591255 [TBL] [Abstract][Full Text] [Related]
12. Current status of monoclonal antibodies for imaging and therapy of prostate cancer. Bander NH Semin Oncol; 1994 Oct; 21(5):607-12. PubMed ID: 7939751 [TBL] [Abstract][Full Text] [Related]
13. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia. Dobosy JR; Roberts JL; Fu VX; Jarrard DF J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351 [TBL] [Abstract][Full Text] [Related]
14. Prostate cancer update 1995. D'Elia FL; Gomella LG Compr Ther; 1995; 21(1):35-40. PubMed ID: 7697980 [TBL] [Abstract][Full Text] [Related]
15. Focused ultrasound ablation of renal and prostate cancer: current technology and future directions. Roberts WW Urol Oncol; 2005; 23(5):367-71. PubMed ID: 16144674 [TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and treatment of localized prostate cancer]. Usami M; Arai Y Hinyokika Kiyo; 1996 Oct; 42(10):759-61. PubMed ID: 8951471 [TBL] [Abstract][Full Text] [Related]
17. Current decision-making in prostate cancer therapy. Cox J; Amling CL Curr Opin Urol; 2008 May; 18(3):275-8. PubMed ID: 18382237 [TBL] [Abstract][Full Text] [Related]
19. [Treatment alternatives of the locally advanced prostate cancer]. PacĂk D Cas Lek Cesk; 2005; 144 Suppl 2():39-44. PubMed ID: 16277184 [TBL] [Abstract][Full Text] [Related]
20. The application of epigenetic modifiers on the treatment of prostate and bladder cancer. Zhang Z; Karam J; Frenkel E; Sagalowsky A; Hsieh JT Urol Oncol; 2006; 24(2):152-60. PubMed ID: 16520279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]